Literature DB >> 21986151

Neurological complications after liver transplantation.

M Yilmaz1, M Cengiz, S Sanli, A Yegin, A Mesci, A Dinckan, N Hadimioglu, L Dosemeci, A Ramazanoglu.   

Abstract

This was a single-centre, prospective study to assess the frequency of neurological complications and their impact on prolonged hospitalization in 137 liver transplant patients presenting between September 1997 and June 2010. Neurological complications were seen in 22 (16%) patients during their postoperative stay in the intensive care unit. Complications included new-onset, recurrent headache (five patients), generalized seizures (four patients), dysarthria (two patients), delirium with agitation (three patients), persistent flapping tremor (two patients), alteration in level of consciousness (three patients), central pontine myelinolysis (one patient), myopathy (one patient) and visual hallucinations (one patient). Seizures were associated with immunosuppressive drug toxicity (tacrolimus). Myopathy presenting as quadriplegia was diagnosed by muscle biopsy. The patient with central pontine myelinolysis lived in a persistent vegetative state for 2 years and died of pneumonia. In conclusion, neurological complications are frequently encountered after liver transplantation, and are an important cause of severe morbidity and prolonged intensive care unit and hospital stay.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21986151     DOI: 10.1177/147323001103900437

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  3 in total

1.  Pearls & Oy-sters: Tacrolimus neurotoxicity presenting as an isolated brainstem lesion.

Authors:  Altaf Saadi; Jeremy D Schmahmann
Journal:  Neurology       Date:  2016-03-15       Impact factor: 9.910

2.  Neurological Complications associated with Pediatric Liver Transplant in Namazi Hospital: One-Year Follow-Up.

Authors:  H Nemati; K Kazemi; A T Mokarram
Journal:  Int J Organ Transplant Med       Date:  2019-02-01

3.  Myalgia in liver transplant recipients after receiving tixagevimab/cilgavimab for pre-exposure prophylaxis of COVID-19: A case series.

Authors:  Hanna L Kleiboeker; Margaret R Jorgenson; Jeannina A Smith
Journal:  Transpl Infect Dis       Date:  2022-08-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.